ENVISIA

Live / Registered — Registered (as of 13 Jan 2026)

What this means for you

Registered since 13 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97815166
Registration number
8098213
Mark type
Stylized text
Filed
28 Feb 2023
Published for opposition
25 Nov 2025
Registered
13 Jan 2026
Attorney of record
Rosaleen H. Chou

Goods and services

  • Class 001 — Chemicals: Reagents for scientific or research use; Diagnostic kits and test kits primarily composed of reagents for determination of genomic and transcriptomic information for scientific or research purposes; Testing kits comprised primarily of preparations, reagents, test strips, collection tubes, buffers, tube holders, transport bags and assays for use in scientific or research in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical and veterinary use; Kits comprised primarily of biological reagents and comprised secondarily of a protocol in the form of printed instructions for use thereof for scientific and research purposes; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for scientific or research purposes; Reagents and molecule or cell markers for scientific or research purposes
  • Class 005 — Pharmaceuticals: Kits for in vitro diagnostic testing for pulmonary diseases and conditions; Reagents for medical use; Molecular diagnostic assays for testing of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Medical preparations used to diagnose bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Diagnostic agents, preparations and substances for medical purposes; Diagnostic test kits consisting primarily of reagents for use in testing bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Medical diagnostic test kits consisting primarily of reagents for detecting pathogens; Clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; Clinical, genetic and specialized medical diagnostic test kits comprised primarily of buffers, collection tubes, tube holders, transport bags, shipping containers, and instruction sheets for use in scientific and clinical diagnostic equipment used to detect disease, cancer, genetics, and pathogens; Chemicals, assays, reagents and kits consisting primarily of chemicals, assays, and reagents for medical testing and diagnostic purposes in the fields of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic reagents, and kits comprised of medical diagnostic reagents, collection tubes, buffers, tube holders, transport bags, and instruction sheets, for diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic testing kits comprised primarily of reagents and assays for use in diagnostics and diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use

Owner

Prosecution history

  • 13 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 13 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
  • 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 25 Nov 2025 — PUBLISHED FOR OPPOSITION
  • 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 28 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 27 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 27 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 27 Oct 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
  • 25 Jun 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 27 Dec 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 28 Jun 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 28 Jun 2024 — LETTER OF SUSPENSION E-MAILED
  • 28 Jun 2024 — SUSPENSION LETTER WRITTEN
  • 29 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED

View this trademark record on Marksy